- Home
- LAZ vs XENE Comparison
LAZ vs XENE Comparison
Compare LAZ & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LAZ | XENE |
|---|---|---|
| Founded | 1848 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LAZ | XENE |
|---|---|---|
| Price | $38.30 | $39.03 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 18 |
| Target Price | $43.00 | ★ $71.75 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 10-22-2026 | 11-09-2026 |
| Dividend Yield | ★ 5.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.20 | N/A |
| Revenue | ★ $3,186,466,000.00 | $311,000.00 |
| Revenue This Year | $6.00 | N/A |
| Revenue Next Year | $19.51 | $2,045.70 |
| P/E Ratio | $33.88 | ★ N/A |
| Revenue Growth | ★ 1.48 | N/A |
| 52 Week Low | $34.13 | $33.38 |
| 52 Week High | $58.75 | $72.66 |
Technical Indicators
Market Signals| Indicator | LAZ | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 50.16 |
| Support Level | $34.65 | $33.38 |
| Resistance Level | $45.71 | $39.92 |
| Average True Range (ATR) | 1.67 | 1.26 |
| MACD | 0.25 | 0.89 |
| Stochastic Oscillator | 53.41 | 77.62 |
Price Performance
Historical ComparisonAbout LAZ Lazard Inc.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.